|
?:authorAffiliation
|
-
[\'Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. Electronic address: barrios@tummi.org.\', \'Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.\', \'Unidad de Epidemiología, Instituto Nacional de Cancerología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.\', \'Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo León, Mexico.\', \'Department of Medical Oncology, Instituto Nacional del Cáncer, Santiago, Chile.\', \'Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.\', \'Liga Colombiana Contra el Cáncer, Bogota, Colombia.\', \'Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.\', \'Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.\', \'Centro de Estudios y Prevención del Cancer Tuxtla Gutiérrez, Chiapas, México; Latin American School of Oncology (ELO), México City, México.\', \'Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Dewpoint Therapeutics, Boston, MA, USA.\', \'Gedyt Foundation, Buenos Aires, Argentina.\', \'Faculty of Medicine, University of Uruguay, Montevideo, Uruguay; Honorary Commission for the Fight Against Cancer, Montevideo, Uruguay.\', \'Center of Strategic Studies of FIOCRUZ (Fundação Oswaldo Cruz), Rio de Janeiro, Brazil.\', \'Teich Health Care Consulting, Rio de Janeiro, Brazil.\', \'Department of Internal Medicine, Advocate Illinois Masonic Medical Center, Chicago, Illinois, USA.\', \'Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Department of Oncology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Unidade de Pesquisa Clínica em Oncologia, Porto Alegre, Brazil.\', \'Department of Medical Oncology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.\', \'Department of Oncology, Hospital Sírio-Libanês, Brasília, Brazil.\', \'Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil.\', \'Medicine Universidad Católica de Honduras, San Pedro Sula, Honduras; Department of Clinical Oncology, Liga Contra el Cáncer, San Pedro Sula, Honduras.\', \'Department of Palliative Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.\', \'Department of Hemato-Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.\', \'Unidad de Cuidados Paliativos y Clínica de Alivio del Dolor Oncológico, Instituto Oncológico Nacional, Ciudad de Panamá, Panamá.\', \'Latin American and Caribbean Society of Medical Oncology (SLACOM), Buenos Aires, Argentina.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}